Overview

Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as carboplatin and topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of topotecan when given together with carboplatin and to see how well they work in treating patients with relapsed or metastatic cervical cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ARCAGY/ GINECO GROUP
Treatments:
Carboplatin
Topotecan